Variable region sequence of specific anti-chlorothalonil antibody and recombinant full-length IgG antibody thereof

A variable region and chlorothalonil technology, applied in the field of genetic engineering, can solve the problems of poor specificity, short preparation cycle, inability to ensure the timeliness and stability of monoclonal antibodies, etc., and achieve high sensitivity and high selectivity

Active Publication Date: 2021-10-29
ZHEJIANG UNIV +1
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The production cycle of polyclonal antibodies is short, but the specificity is relatively poor; based on hybridoma technology, monoclonal antibodies with high recognition sensitivity and strong specificity can be obtained, but hybridoma cells have comple

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Variable region sequence of specific anti-chlorothalonil antibody and recombinant full-length IgG antibody thereof
  • Variable region sequence of specific anti-chlorothalonil antibody and recombinant full-length IgG antibody thereof
  • Variable region sequence of specific anti-chlorothalonil antibody and recombinant full-length IgG antibody thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0019] In order to enable those skilled in the art to better understand the solutions of the present invention, the technical solutions in the embodiments of the invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only It is a part of embodiments of the present invention, but not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative work should belong to the protection scope of the present invention. If there is no special description, the experimental methods in the embodiments are all for the conventional method.

[0020] The anti-chlorothalonil recombinant full-length IgG antibody involved in the present invention includes a heavy chain constant region, a heavy chain variable region, a light chain constant region and a light chain variable regio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a variable region sequence of a specific anti-chlorothalonil antibody. The amino acid sequence of a heavy chain variable region coding gene is shown in SEQ ID NO: 2. The invention also discloses an anti-chlorothalonil recombinant full-length IgG antibody. The invention also discloses a recombinant antibody expression plasmid. The heavy chain variable region and light chain variable region sequences of the anti-chlorothalonil recombinant full-length IgG antibody are derived from a monoclonal cell strain which secretes a high-affinity and high-specificity anti-chlorothalonil antibody and is obtained by immunizing mice for multiple times, performing cell fusion and screening. The sequence genes are respectively connected to expression vectors containing a mouse IgG1 heavy chain constant region gene and a mouse kappa light chain constant region gene, the recombinant full-length IgG antibody is obtained by expression of mammalian cells of a double-plasmid system, the recognition activity of the recombinant full-length IgG antibody is very close to that of a mouse-derived parent antibody, large-scale standardized production of the anti-chlorothalonil antibody can be realized, and reliable core raw materials are provided for various immunoassay methods for rapid detection of chlorothalonil residues.

Description

technical field [0001] The invention belongs to the technical field of genetic engineering, and in particular relates to the preparation and application of a variable region sequence of a specific anti-chlorothalonil antibody and a recombinant full-length IgG antibody. Background technique [0002] Chlorothalonil is a broad-spectrum, protective fungicide that can interact with glyceraldehyde triphosphate dehydrogenase in fungal cells and combine with the cysteine-containing protein in the enzyme to destroy the enzyme activity. The metabolism of the fungal cells is destroyed and the vitality is lost. Chlorothalonil can effectively kill fungi such as Ascomycetes, Deuteromycetes, and Basidiomycetes, but it is highly toxic to non-target organisms, especially fish, and can cause delayed allergic dermatitis in humans. Therefore, the European Commission released The regulations prohibit the use of chlorothalonil and include it in the list of class 2B carcinogens. In addition, wit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K16/44C12N15/85
CPCC07K16/44C12N15/85C07K2317/56C07K2317/92C07K2317/52Y02A50/30
Inventor 郭逸蓉柳颖赵颖占绣萍刘毅华赵莉陆昕颖朱国念
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products